Further investigations are warranted to ascertain whether miR also contributes to a tumor metastatic property via CD36 and how the CD36-mediated miR–lipoprotein complex internalization shuttles miR to the RNA-induced silencing complex to elicit their gene regulatory effects. The gene discussed is CD36; the disease is neoplasm.